Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Delay In Approval Of U.S.-Korea Free Trade Agreement Could Give EU Companies Advantage Over U.S. Counterparts

This article was originally published in PharmAsia News

Executive Summary

SEOUL - U.S. President Barack Obama and South Korean President Lee Myung-bak failed to finalize a revised free trade agreement at the G20 Seoul Summit, raising the likelihood that the U.S. will be unable to ratify the agreement before a similar EU-Korea pact

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts